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Abstract
Leukoaraiosis is a pathological appearance of the brain white matter, which has long been believed to be caused 
by perfusion disturbances within the arterioles perforating through the deep brain structures. Due to its complex 
etio pathogenesis and clinical relevance, leukoaroisosis has been investigated in a multitude of studies. As regards  
the clinical implications of leukoaraiosis, this neuroimaging finding is strongly related to ischaemic stroke, unfa-
vourable course of ischaemic stroke in the acute phase, worse long-term outcomes, and cognitive disturbances.  
The morpholo gical changes in the deep white matter that are collectively described as leukoaraiosis, despite a seem-
ingly homogenous appearance, probably resulting from various causes, such as atherosclerosis, neurotoxic factors 
including radiation therapy and chemotherapy, and neuroinfections. Based on our experience and recent literature, 
we present the symptomatology of leukoaroisosis and similar radiological abnormalities of the cerebral white matter. 
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Introduction
Although leukoaroisosis was first described by Hachinski 
30 years ago, it has remained an important and widely stud-
ied research topic, especially regarding its aetiology and 
clinical correlates. The term leukoaraiosis refers to neuro-
imaging abnormalities of the white matter, which appear as 
hypodense or hyperintense areas, are located predominantly 
in the periventricular area, and are found especially in older 
people [1,2]. The term was originally coined by Hachinski 
in 1987 (leuko – white, araiosis – rarefaction), and it referred 
to the ischaemic abnormalities observed in the deep white 
matter of the brain. The appearance of leukoaraiosis de-
pends on the imaging method used, but typically it presents 
as multifocal or diffuse periventricular or subcortical lesions 
of varying sizes. These lesions have a hypoxic-ischemic 
aetiology, with axonal atrophy and consequent gliosis that 
occurs due to an interplay of numerous factors [1,3]. 
Pathomechanism
Leukoaraiosis is caused by hypoxia-ischaemia that results 
from diseases of the small vessels, typically the thalam-
ostriate arteries and other perforating arteries. However, 
there are controversies regarding the causes of stenosis or 
occlusion of these vessels. With aging, arteries loose elas-
ticity due to accumulation of atherosclerotic plaques, am-
yloid, and hyalinisation, which leads to ischaemia and gli-
osis with consequent neurotransmission disorders [1,4]. 
Hypoxia-ischaemia is supposed to play a role in the ae-
tiology of leukoaraiosis; however, it is not certain whether 
it is a primary or a secondary cause, i.e. whether decreased 
blood flow is the cause or effect of nerve cell damage [4]. 
Another hypothesis focuses on blood-brain barrier 
breakdown and endothelial dysfunction [1,4,5], with hae-
modynamic disturbances and damage of the blood-brain 
barrier being interpreted as elements of endothelial dys-
 Leukoaraiosis – new concepts and modern imaging
e77© Pol J Radiol 2018; 83: e76-e81
function [4]. The blood-brain barrier damage is reflected 
by the presence of plasma proteins such as IgG, comple-
ment, and fibrinogen in patients with leukoaraiosis. Thus, 
it is supposed that brain damage is due to toxic effects of 
blood proteins on nerve cells [4]. 
Clinical aspects
Although the pathogenesis of leukoaraiosis is not com-
pletely understood, it is thought that its prevalence in-
creases with age [3], especially in people over 60 years of 
age [1]. Other risk factors include female gender, hyper-
tension, heart diseases, type 2 diabetes, abdominal obe-
sity, hyperlipidaemia, hyperhomocysteinaemia, carotid 
stenosis – patients with stroke and leukoaraiosis have an 
increased thickness of the intima-media complex [2,6], 
history of stroke, tobacco use, alcohol abuse, and chron-
ic kidney diseases [1,3-6]. Notably, some studies have 
shown that age and the intima-media thickness are more 
strongly associated with leukoaraiosis than other cardio-
vascular risk factors, and the severity of carotid athero-
sclerosis reflects the severity of white matter lesions [2]. 
Leukoaraiosis is associated with stroke - especially lacunar 
stroke, vascular dementia, and Alzheimer’s disease [4,7]. 
An increased rigidity of small arteries in patients with 
Alzheimer’s disease or vascular dementia suggests a causal 
relationship between this finding and these diseases [7]. 
Some studies have found an association between leu-
koaraiosis and depression or mood disorders, as well as 
disability in elderly people [3,4,6]. The clinical picture of 
patients with leukoaraiosis is diverse and includes motor 
deficits, frequent falls, parkinsonism, and pseudobulbar 
syndrome [1,4,5]. 
It has also been shown that most patients with neurologi-
cal deficits and leukoaraiosis also have cognitive impairment 
[4]. Leukoaraiosis is also regarded as an independent risk 
factor of death in people with vascular disorders. Similarly, 
leukoaroisosis increases the risk of stroke and myocardial 
infarction, and predicts complications of stroke, such as ep-
ilepsy, pneumonia in the acute phase of stroke, and trauma 
due to falls resulting from motor deficits [1,4,6]. The pres-
ence of leukoaraiosis does not influence the management of 
patients after stroke or transient ischaemic attacks (TIA) [6]; 
however, adequate care should be given when administering 
oral anticoagulation as secondary prophylaxis of ischaemic 
stroke in patients with leukoaraiosis because of a perceived 
increased risk of intracranial bleeding [1]. Notably, hyperten-
sion is a risk factor for both leukoaraiosis and intracerebral 
bleeding [6]. The risk of bleeding cannot be estimated based 
on the location or severity of leukoaraiosis, but the extent of 
leukoaraiosis might correlate with bleeding risk [4,6]. 
Imaging of leukoaraiosis:
The term leukoaraiosis was introduced based on comput-
ed tomography (CT) images, but leukoaraiotic lesions can 
be visualised with magnetic resonance imaging (MRI), 
especially with SE T2, and FLAIR sequences [4]. Typi-
cally, leukoaraiotic lesions are multifocal or diffuse, with 
indistinct borders [8], are most commonly located in the 
proximity of the cerebral ventricles or within the semiov-
al centre and appear hypodense in comparison to normal 
white matter on CT images. On MRI, these lesions are hy-
perintense on T2 and FLAIR images [1,2] (Figures 1 and 2).
Based on neuroimaging, the severity of leukoaraiosis 
can be assess using various scales, depending on the im-
aging modality used, i.e. CT or MRI [8]. Leukoaraiotic 
lesions can be found earlier on MRI, hence they do not al-
ways co-occur with neurological deficits. In contrast, such 
a correlation between radiological appearance and neuro-
logical deficits can be observed in the case of CT because 
the lesions found on CT reflect a greater severity of neuro-
degeneration [1]. 
Among the many CT scales that are used for grading 
the severity of leukoaraiosis are those developed by Erkin-
junttiet et al. in 1987, Rezek et al., as well as the scales 
published in 1991-1995 by Blennow et al., Charletta et al., 
and Lopez et al. [8]. However, the scale developed in 1992 
by van Swieten et al. has been used most commonly both 
for CT and MRI. In this scale, the “anterior” and “posteri-
or” portions of each brain slice are evaluated separately at 
the level of the vascular plexuses of the posterior ventricu-
lar horns, the central part of the lateral ventricles, and the 
corona radiate, according to the following grading score: 
0 – no lesions, 1 – partial involvement of the white mat-
ter, and 2 – involvement extending the subcortical areas; 
the maximum score is 4 for the “anterior” and “posterior” 
parts [8]. With the advancement of MRI, several scales 
for this modality have been proposed for assessing the 
severity of white matter involvement, ranging from sim-
ple dichotomous scales to numerous detailed scales put 
forward by Awad et al., Gerard and Weisberg, Figiel et al., 
Schmidt et al., Scheltens et al., Breteler et al., Victoroff et 
al., Manolio et al., and Fukuda et al. [8]. It should be noted 
that the scale developed by Fazekas et al. in 1987 has been 
used most commonly in clinical practice. This four-point 
scale assesses periventricular white matter (PVWM) in-
volvement and deep white matter (DWM) involvement. 
The grading system for the periventricular matter is as 
follows: 0 – no lesions, 1 – “caps” or pencil-thin lining, 
2 – smooth “halo”, and 3 – irregular periventricular signal 
extending into the deep white matter. The grading sys-
tem for the deep white matter is as follows: 0 – no lesions, 
1 – punctate foci, 2 – beginning confluence, and 3 – large, 
confluent areas [8]. Advanced white matter lesions, with 
a score of 3, are morphologically similar to leukoaraiosis. 
It is difficult to ascertain which of the above-described 
scales is the most precise. Some of them emphasise the 
size and number of lesions, whereas others assess the 
percentage involvement of the white matter or halo-like 
and pencil-thin lesions. The majority of scales, at least to 
some degree, refer to the anatomical areas in which leu-
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koaraiotic lesions tend to occur. Owing to a better tissue 
resolution, MRI enables detailed analysis of leukoaraiotic 
lesions. As regards simple scales, evaluation of the sever-
ity of leukoaraiosis can be difficult due to the subjective 
nature of assessments and the experience of the rater. On 
the other hand, using complex and time-consuming scales 
may not be feasible in busy clinical settings. Based on a re-
view of the relevant literature, we found the scales of van 
Swieten for CT and Fazekas for MRI to be the most com-
monly used in clinical practice. 
Lesions that are similar to leukoaraiosis can be found 
in adult patients with other diseases, such as Alzheimer’s 
disease, vascular dementia, amyloid angiopathy, cerebral 
autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL), Binswanger’s dis-
ease, hypertensive encephalopathy, after chemotherapy, 
soft tissue diseases, multiple sclerosis, HIV, and Hashimoto 
encephalopathy [3,6]. 
According to recent reports, classifications of small ves-
sel diseases, which are based on aetiology, specify diseases 
associated with atherosclerosis as a separate category; other 
categories include inflammatory and autoimmune diseas-
es, such as Wegener’s granulomatosis, Churg-Strauss Syn-
drome, Schönlein-Henoch disease, and soft tissue diseases 
– Sjögren syndrome, scleroderma, rheumatoid angiitis, and 
systemic lupus erythematosus. Other categories include he-
reditary amyloid angiopathy and other hereditary diseases 
that are not associated with amyloid deposition, such as 
CADASIL, cerebral recessive dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CARASIL), 
Fig. 1. Computed tomography brain images at the level of the ventricular system show the respective grades of severity of leukoaraiosis. A) Grade 1 on 
the scale by van Swieten – small hypodense lesions can be seen around the anterior horns of the lateral cerebral ventricles. B) Grade 2 on the scale by van 
Swieten – diffuse, confluent hypodense lesions can be seen around the posterior horn of the lateral cerebral ventricles that extend to the cerebral cortex. 
C) Grade 3 on the scale by van Swieten – lesions extending to the subcortical areas are seen in the posterior horns of the lateral ventricles; leukoaraiotic 
lesions are less pronounced in the anterior part of the brain. D) Grade 4 on the scale by van Swieten – diffuse hypodense lesions are seen around the ven-
tricles and in the semioval centres 
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Fig. 2. Brain MRI, T2, and FLAIR sequences at the level of the ventricular system show leukoaraiosis. A-B) Mild hyperintense lesions are seen as small, 
disseminated, blurry foci – grade 1 according to Fazekas. C-D) Moderate lesion are seen as disseminated and confluent foci of abnormal signal intensity 
around the ventricles and in the subcortical areas – grade 2 according to Fazekas. E-F) Severe leukoaraiotic lesions are seen as confluent and disseminated 
hyperintense foci – grade 3 according to Fazekas
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mitochondrial encephalomyopathy, lactic acidosis, stroke-
like episodes (MELAS), and Fabry disease [9]. 
Recently, new research has been published that is in 
line with previous hypotheses regarding the aetiopatho-
genesis and clinical picture of leukoaraiosis. Junying Shi 
et al. proposed that leukoaroisosis is associated with age 
– with greater prevalence in people over 60 years of age, 
hypertension, history of cerebral bleeding, ischaemic 
stroke, lacunar stroke, and hypertriglyceridaemia [10]. 
Other researchers regard leukoaroisosis as an independ-
ent predictive factor of cognitive function impairment 
after mild ischaemic stroke (NIHSS ≤ 5) [11]. Based on 
recent reports, leukoaraiosis is an important cause of dis-
ability, cognitive function impairment, gait disturbances, 
incontinence, dysarthria, and, most importantly, ischae-
mic stroke. Diseases that co-occur with leukoaraiosis 
include well-known stroke risk factors, such as hyperho-
mocysteinaemia, hypertension, dyslipidaemia, diabetes, 
tobacco use, ischaemic heart disease, history of lacunar 
stroke, atrial fibrillation, and chronic renal failure [12]. 
Based on current stroke management guidelines, mild or 
severe leukoaraiosis (2-4 points on the scale by van Swi-
eten) negatively influences clinical outcomes in patients 
after recanalisation of cerebral vessels in the acute phase 
of ischaemic stroke [13]. Notably, Urška Lamot et al. re-
ported in 2017 that the central vein sign on SWI-MRI is 
not only characteristic for multiple sclerosis but is also 
frequently found in small vessel diseases associated with 
leukoaraiosis [14]. As regards multiple sclerosis, the cen-
tral vein sign is explained by perivascular inflammatory 
infiltrates around central veins; in leukoaraiosis, it can be 
due to signal void in central veins that is seen against the 
background of gliosis. 
Asian neurologists have also shed new light on the 
pathogenesis of leukoaraiosis and its relation to small 
vessel diseases. They have found a relationship between 
leukoaraiosis and retinopathy in patients with anterior 
circulation stroke [15]. 
Discussion
In 2013, an international group of researchers character-
ised neuroimaging features of small vessel diseases [16]. 
These features include recent small subcortical infarcts, 
lacunes, white matter hyperintensities, periventricular 
spaces, microbleeds, and brain atrophy. Unification of 
radiological terminology is important because lesions 
associated with small vessel diseases are the most fre-
quent cause of vascular dementia, and to date, numerous 
terms with differing definitions have been used in both 
research and clinical practice. Based on the above-men-
tioned statement, leukoaraiosis, similarly to other sym-
metrical T2-hyperintese and CT-hypodense white mat-
ter lesions, is thought to have a vascular aetiology in 
contrast to other diseases, such as multiple sclerosis and 
leukodystrophies, in which similar lesions have a differ-
ent nature [16]. 
Conclusions
Leukoaraiosis is a significant risk factor of ischaemic 
stroke as well as neurological and cognitive impairment. 
Leukoaraiosis and its severity, which can be graded on 
numerous scales, is associated with negative outcomes in 
the acute phase of stroke and after stroke, and is an inde-
pendent risk factor of recurrent stroke; thus, patients with 
leukoaraiosis required special care. Based on our own ex-
perience and the available literature regarding MRI-hy-
perintense and CT-hypodense white matter lesions, we 
suggest that leukoaraiosis should be redefined because 
many other white matter lesions have a similar neuroim-
aging appearance that is not due atherosclerotic changes 
in small vessels. 
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